Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Xuan En Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh and Qi Zeng ()
Additional contact information
Min Thura: Agency for Science, Technology and Research (A*STAR)
Abdul Qader Al-Aidaroos: Agency for Science, Technology and Research (A*STAR)
Abhishek Gupta: Agency for Science, Technology and Research (A*STAR)
Cheng Ean Chee: National University Cancer Institute, Singapore (NCIS)
Soo Chin Lee: National University Cancer Institute, Singapore (NCIS)
Kam Man Hui: National Cancer Centre Singapore
Jie Li: Agency for Science, Technology and Research (A*STAR)
Yeoh Khay Guan: National University of Singapore
Wei Peng Yong: National University Cancer Institute, Singapore (NCIS)
Jimmy So: National University Cancer Institute, Singapore (NCIS)
Wee Joo Chng: National University Cancer Institute, Singapore (NCIS)
Chin Hin Ng: National University Cancer Institute, Singapore (NCIS)
Jianbiao Zhou: National University Cancer Institute, Singapore (NCIS)
Ling Zhi Wang: National University of Singapore
John Shyi Peng Yuen: Singapore General Hospital
Henry Sun Sien Ho: Singapore General Hospital
Sim Mei Yi: Singapore General Hospital
Edmund Chiong: National University Cancer Institute, Singapore (NCIS)
Su Pin Choo: National Cancer Centre Singapore
Joanne Ngeow: Agency for Science, Technology and Research (A*STAR)
Matthew Chau Hsien Ng: National Cancer Centre Singapore
Clarinda Chua: National Cancer Centre Singapore
Eugene Shen Ann Yeo: Singapore General Hospital
Iain Bee Huat Tan: National Cancer Centre Singapore
Joel Xuan En Sng: Agency for Science, Technology and Research (A*STAR)
Nicholas Yan Zhi Tan: Agency for Science, Technology and Research (A*STAR)
Jean Paul Thiery: Agency for Science, Technology and Research (A*STAR)
Boon Cher Goh: National University Cancer Institute, Singapore (NCIS)
Qi Zeng: Agency for Science, Technology and Research (A*STAR)

Nature Communications, 2021, vol. 12, issue 1, 1-1

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-021-26548-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-26548-6

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-26548-6

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().